Diabetes Canada2018EN
Diabetes Canada Chapter 28: Treatment of Diabetes in People with Heart Failure
Zusammenfassung
KEY MESSAGES:
Key Messages Heart failure is still under-recognized and misdiagnosed. This has significant clinical implications as the prognosis of untreated or undertreated heart failure is poor, and yet very effective proven therapies are widely available to most. Diabetes can cause heart failure independently of ischemic heart disease by causing a diabetic cardiomyopathy that may manifest in the setting of normal or reduced left ventricular ejection fraction. The incidence of heart failure is
Kerninformationen
Introduction Type 2 diabetes often occurs in association with other cardiovascular (CV) risk factors, such as hypertension, dyslipidemia, smoking and obesity, which, together, are strongly associated with atherosclerosis, ischemic heart disease and left ventricular (LV) dysfunction (1) . LV dysfunct...
e proven therapies are widely available. Because of this, many studies have explored the clinical utility of screening people with diabetes for the presence of reduced LV function with BNP/NT-pro- BNP testing. The results to date are mixed, with no clear consensus to institute this strategy. A recen...
r systolic and diastolic function, independently from ischemic heart disease or systemic hypertension. While an increase in glycated hemoglobin (A1C) among individuals with diabetes is a recognized risk factor for heart failure (8-12) , no prospective study to date has demonstrated that improved gly...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
Diabetes Canada2018
Diabetes Canada Chapter 23: Cardiovascular Protection in People with Diabetes
StatPearls2026
StatPearls: Sodium-Glucose Transport 2 (SGLT2) Inhibitors
DDG2026
DDG: Therapy_Type_2.pdf pdf
CCS2023
CCS 2023 Cardiorenal Risk Reduction Guidelines: GLP-1 RA and SGLT2i
StatPearls2026